Functional brain imaging study for functional and/or organic psychiatric disorders

Functional brain imaging study for functional and/or organic psychiatric disorders - Functional brain imaging study for functional and/or organic psychiatric disorders

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016752

Enrollment

150

Registered

2015-03-10

Start date

2005-05-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, other functional psychiatric disorders and/or organic psychiatric disorders

Interventions

Antipsychotic drug, PET, CT or MRI, neuropsychological test Antipsychotic drug, PET, CT or MRI, neuropsychological test PET, CT or MRI, neuropsychological test drug trials of &lt

1000 mg per day chlorpromazine equivalents, in or outpatient status of at least 1 year

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Inpatients or outpatients of Kagoshima University Hospital or Fujimoto Hospital those who are diagnosed by DSM-4, and ICD-10 2) Subjects with schizophrenia, other functional psychiatric disorders or organic psychiatric disorders

Exclusion criteria

Exclusion criteria: Subjects with head trauma, alcohol or drug abuse in past times

Design outcomes

Primary

Measure	Time frame
Brain imaging studies (MRI, SPECT, PET), scales for the objective assessment	—

Countries

Japan

Contacts

Public ContactMasayuki Nakamura

Kagoshima University Graduate School of Medical and Dental Sciences Department of Psychiatry

nakamu36@m.kufm.kagoshima-u.ac.jp099-275-5346

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026